Medline Inc. (MDLN) Earnings
Medline Inc.'s most recently reported earnings, recent earnings filings (8-K) and headline annual financials, sourced from SEC EDGAR.
Last reported earnings
Aug 5, 2026
From the latest earnings 8-K
Revenue • FY2025
$28.43B
As reported
Diluted EPS • FY2025
$-0.01
As reported
Reported earnings dates are based on the latest 8-K (Item 2.02) filings. The next earnings date is an estimate projected from MDLN's historical reporting pattern, not a company-confirmed date.
Headline financials
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $28.43B | $1.16B | $7.52B | $-0.01 | $1.3B | 7.8% | — |
Recent earnings filings
| Filed | Form | Accession |
|---|---|---|
| Aug 5, 2026 | 8-K (2.02) | 0002046386-26-000049EDGAR |
| May 6, 2026 | 8-K (2.02) | 0002046386-26-000022EDGAR |
| Feb 25, 2026 | 8-K (2.02) | 0002046386-26-000007EDGAR |
Earnings for companies related to MDLN
Never miss a MDLN filing.
Get an email when MDLN files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Oct 17, 2026Source: SEC EDGAR.